Egypts Asthma drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Asthma is a chronic inflammatory lung disease. It affects people of all ages but mostly starts in childhood. It creates inflammation in the inside walls of the airways which makes airways very sensitive to an allergic reaction. Asthma may be caused due to genetic, environmental factors, or a combination of both.

Asthma treatment market is gradually growing due to the rise in smoking and tobacco use among the population. The problem is further worsened by the rising air pollution. InEgypt, theprevalence of asthmain children (2-12 years) is nearly 8.2%.

Market Drivers

Increasing incidence of asthma cases, advanced inhaler devices, innovation in biological drugs, rise in the death rates, increasing pollution level, growing aging population are expected to drive the market for asthma treatment, in addition, increasing population of smokers, rise in disposable income, increasing awareness about the benefits of timely diagnosis of asthma and growing demand for better healthcare facilities are expected to drive the market for asthma treatment.

However, the increasing number of patent expiration of drugs, rise in the use of generic drugs, and high cost of asthma treatment are some of the major factors restraining the growth of the global asthma treatment market.